trial · primary record
Biopsy Procedure
Malignant Glioma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 132 |
| Primary completion | 2027-06-30 |
| Primary endpoint | Maximum tolerated dose |
| Registry ID | NCT05099003 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:03.278Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05099003
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biopsy Procedure · compound